134 related articles for article (PubMed ID: 9249023)
1. Enhanced stability of urokinase-type plasminogen activator mRNA in metastatic breast cancer MDA-MB-231 cells and LLC-PK1 cells down-regulated for protein kinase C--correlation with cytoplasmic heterogeneous nuclear ribonucleoprotein C.
Nanbu R; Montero L; D'Orazio D; Nagamine Y
Eur J Biochem; 1997 Jul; 247(1):169-74. PubMed ID: 9249023
[TBL] [Abstract][Full Text] [Related]
2. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
Montero L; Nagamine Y
Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
[TBL] [Abstract][Full Text] [Related]
3. Multiple instability-regulating sites in the 3' untranslated region of the urokinase-type plasminogen activator mRNA.
Nanbu R; Menoud PA; Nagamine Y
Mol Cell Biol; 1994 Jul; 14(7):4920-8. PubMed ID: 8007988
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells.
Ziegler A; Knesel J; Fabbro D; Nagamine Y
J Biol Chem; 1991 Nov; 266(31):21067-74. PubMed ID: 1718970
[TBL] [Abstract][Full Text] [Related]
5. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
[TBL] [Abstract][Full Text] [Related]
6. Staurosporine stimulates expression of the urokinase-type (u-PA) plasminogen activator in LLC-PK1 cells.
Dierks-Ventling C; Knesel J; Nagamine Y; Hemmings BA; Pehling G; Fischer F; Fabbro D
Int J Cancer; 1989 Nov; 44(5):865-70. PubMed ID: 2583867
[TBL] [Abstract][Full Text] [Related]
7. A new genetic approach for studying hormonal regulation of urokinase-type plasminogen activator gene expression in LLC-PK1 cells.
Hofstetter P; Kikinis Z; Altus MS; Pearson D; Nagamine Y
Mol Cell Biol; 1987 Dec; 7(12):4535-41. PubMed ID: 2830499
[TBL] [Abstract][Full Text] [Related]
8. hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP.
Andrus L; Altus MS; Pearson D; Grattan M; Nagamine Y
J Biol Chem; 1988 May; 263(13):6183-7. PubMed ID: 3360780
[TBL] [Abstract][Full Text] [Related]
9. Protein synthesis and urokinase mRNA metabolism.
Shetty S
Mol Cell Biochem; 2005 Mar; 271(1-2):13-22. PubMed ID: 15881651
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
Tran H; Maurer F; Nagamine Y
Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
[TBL] [Abstract][Full Text] [Related]
11. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
[TBL] [Abstract][Full Text] [Related]
12. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.
Velusamy T; Shetty P; Bhandary YP; Liu MC; Shetty S
Biochemistry; 2008 Jun; 47(24):6508-17. PubMed ID: 18494499
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.
Ziegler A; Hagmann J; Kiefer B; Nagamine Y
J Biol Chem; 1990 Dec; 265(34):21194-201. PubMed ID: 1701176
[TBL] [Abstract][Full Text] [Related]
15. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
16. Induction of uPA but not NF-IL3A by calcitonin is dependent on Erk1/2 phosphorylation in porcine renal cell line LLC-PK1.
Nakamura M; Yang Q; Ozaki T; Nakamura Y; Yamasaki H; Mori I; Kakudo K
Biochem Biophys Res Commun; 2002 Feb; 290(5):1483-8. PubMed ID: 11820789
[TBL] [Abstract][Full Text] [Related]
17. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
18. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
Marksitzer R; Stief A; Menoud PA; Nagamine Y
J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
[TBL] [Abstract][Full Text] [Related]
19. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
20. Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells.
Rondeau E; Guidet B; Lacave R; Bens M; Sraer J; Nagamine Y; Ardaillou R; Sraer JD
Biochim Biophys Acta; 1990 Nov; 1055(2):165-72. PubMed ID: 2122915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
